Promising combo aims to wipe out early breast cancer before surgery
NCT ID NCT06604858
First seen Dec 24, 2025 · Last updated May 19, 2026 · Updated 21 times
Summary
This study tests whether adding the immunotherapy drug pembrolizumab to standard chemotherapy can eliminate all signs of cancer in people with early-stage triple-negative breast cancer before they have surgery. About 31 participants with small tumors (1 to 2.5 cm) that haven't spread to lymph nodes will receive the combination. The main goal is to see how many have no cancer left at the time of surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Complejo Hospitalario Universitario A Coruña (CHUAC)
A Coruña, Spain
-
Complejo Hospitalario Universitario de Santiago (CHUS)
Santiago de Compostela, Spain
-
Hospital Arnau de Vilanova de Valencia
Valencia, Spain
-
Hospital Beata María Ana
Madrid, Spain
-
Hospital Cínico San Carlos
Madrid, Spain
-
Hospital Universitari Dexeus
Barcelona, Spain
-
Hospital Universitari Vall D'Hebron
Barcelona, Spain
-
Hospital Universitario Clínico San Cecilio de Granada
Granada, Spain
-
Hospital Universitario Virgen del Rocío
Seville, Spain
-
Hospital Universitario de Navarra
Pamplona, Spain
-
Institut Català d' Oncologia Girona (ICO)
Girona, Spain
Conditions
Explore the condition pages connected to this study.